Sector: In Vitro & In Vivo Diagnostic SubstancesIndustry: Medical - Instruments & SuppliesCountry: DEExchange: Nasdaq
DilutionScan read 16 of Anbio Biotechnology's SEC filings and found 1 shelf registration, 1 S-1 registration and 1 completed offering on file for NNNN. The latest dilution event on file is a registration statement on Jul 9, 2026. Analysis updated Nov 2, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Medical - Instruments & Supplies. All tickers A to Z
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares
OSUROraSure Technologies, Inc.
UTMDUtah Medical Products, Inc.
PDEXPro-Dex, Inc.
KRMDKORU Medical Systems, Inc.
STXSStereotaxis, Inc.
POCIPrecision Optics Corporation, Inc.
DXRDaxor Corporation
HBIOHarvard Bioscience, Inc.
NEPHNephros, Inc.
MLSSMilestone Scientific Inc.
RVPRetractable Technologies, Inc.
BNGOBionano Genomics, Inc.
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares
FEMYFemasys Inc.